Meeder Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | -$7 | – | 471 |
|
|
2023
Q3 | – | Hold |
0
| – | -$22 | – | 484 |
|
|
2023
Q2 | – | Hold |
0
| – | -$109 | – | 500 |
|
|
2023
Q1 | – | Sell |
-6
| Closed | -$7.6K | – | 582 |
|
|
2022
Q4 | $7.6K | Hold |
6
| – | – | ﹤0.01% | 667 |
|
|
2022
Q3 | $5K | Hold |
6
| – | – | ﹤0.01% | 1537 |
|
|
2022
Q2 | $9K | Hold |
6
| – | – | ﹤0.01% | 1398 |
|
|
2022
Q1 | $13K | Buy |
+6
| New | +$13K | ﹤0.01% | 1443 |
|
|
2021
Q4 | – | Sell |
-7
| Closed | -$43K | – | 1245 |
|
|
2021
Q3 | $43K | Hold |
7
| – | – | ﹤0.01% | 1136 |
|
|
2021
Q2 | $64K | Buy |
7
+4
| +133% | +$36.6K | ﹤0.01% | 1045 |
|
|
2021
Q1 | $31K | Buy |
+3
| New | +$31K | ﹤0.01% | 1265 |
|
|
2020
Q4 | – | Sell |
-2
| Closed | -$10K | – | 1882 |
|
|
2020
Q3 | $10K | Hold |
2
| – | – | ﹤0.01% | 1365 |
|
|
2020
Q2 | $12K | Hold |
2
| – | – | ﹤0.01% | 1257 |
|
|
2020
Q1 | $11K | Hold |
2
| – | – | ﹤0.01% | 1461 |
|
|
2019
Q4 | $29K | Hold |
2
| – | – | ﹤0.01% | 1225 |
|
|
2019
Q3 | $22K | Buy |
+2
| New | +$22K | ﹤0.01% | 1266 |
|